Jun Liang

10PUBLICATIONS
12CO-AUTHORS
Molecular targetsCarbon capture engineering (excl. sequestration)Solid tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 13, 2025
Anlotinib in progressive RAI-refractory differentiated thyroid cancer: long-term results and PET/CT prognostic markers.

Di Sun, Xin Zhang, Yingqiang Zhang

|Feb 09, 2025
BRAFV600E mutation is associated with better prognoses in radioactive iodine refractory thyroid cancer patients treated with multi-kinase inhibitors: a retrospective analysis of registered clinical trials.

Di Sun, Xin Zhang, Xiaona Jin

|Dec 18, 2023
Correction: In vitro CRISPR screening uncovers CRTC3 as a regulator of IFN-γ-induced ferroptosis of hepatocellular carcinoma.

Li Li, Tao Xing, Yiran Chen

|Dec 07, 2023
Characterizing Genetic Alterations Related to Radioiodine Avidity in Metastatic Thyroid Cancer.

Zhuanzhuan Mu, Xin Zhang, Di Sun

|Sep 04, 2023
In vitro CRISPR screening uncovers CRTC3 as a regulator of IFN-γ-induced ferroptosis of hepatocellular carcinoma.

Li Li, Tao Xing, Yiran Chen

|Aug 25, 2023
Fusion Oncogenes in Patients With Locally Advanced or Distant Metastatic Differentiated Thyroid Cancer.

Gaoda Ju, Yuqing Sun, Hao Wang

Pageof 2

Frequent Collaborators

7 joint publications

Yansong Lin

2 joint publications

Gaoda Ju

2 joint publications

Cihui Yan

2 joint publications

Xiubao Ren